Viewing Study NCT07042295


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2025-12-25 @ 10:55 PM
Study NCT ID: NCT07042295
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module